Patient with agammaglobulinemia produces anti-SARS-CoV-2 reactive T-cells after CoronaVac vaccine. Clinics, [S. l.], v. 77, p. 100007, 2022. DOI: 10.1016/j.clinsp.2022.100007. Disponível em: https://revistas.usp.br/clinics/article/view/213624.. Acesso em: 20 may. 2024.